New stent aims to seal brain aneurysms without surgery
NCT ID NCT07190781
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a drug-coated stent designed to block blood flow into unruptured brain aneurysms, helping them heal. Researchers will follow 280 patients for 12 months after the stent is placed, checking how well the aneurysm closes and watching for any complications. The goal is to confirm the stent is safe and works as intended.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Lattice Flow-Diverting Dense-Mesh Stent (a drug-eluting stent device)
What this could lead to
If successful, this stent could offer a safer, more effective way to treat unruptured brain aneurysms without open surgery.
What could go wrong
This is a post-marketing study, so the device is already approved. However, results may vary, and risks like incomplete healing or complications remain possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL ANEURYSM UNRUPTURED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100070, China